A case of mixed neuroendocrine carcinoma–acinar adenocarcinoma: Utilization of triplet therapy for prostate cancer

We demonstrated the first case in which triplet therapy had been effective in the treatment of neuroendocrine prostate cancer.

Authors

Institutions

Publication Details

Journal
IJU Case Reports
Published
2024-09-01
DOI
https://doi.org/10.1002/iju5.12778
Citations
1
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A case of mixed neuroendocrine carcinoma–acinar adenocarcinoma: Utilization of triplet therapy for prostate cancer

Katsunori Uchida, Takahiro Nakamoto, Yuki Masuo, Junichi Ikeda et al.
1 citations
IJU Case Reports
Prostate Cancer Treatment and Research
0.42
article

A case of mixed neuroendocrine carcinoma–acinar adenocarcinoma: Utilization of triplet therapy for prostate cancer

Katsunori Uchida, Takahiro Nakamoto, Yuki Masuo, Junichi Ikeda, Hidefumi Kinoshita, Hisanori Taniguchi, Hiroki Takayama
article en
1 citations

Abstract

We demonstrated the first case in which triplet therapy had been effective in the treatment of neuroendocrine prostate cancer.

IJU Case ReportsVol. 7(6)
Kansai Medical University (JP)
Good health and well-being
Openalex Percentile: Top 33%
Prostate Cancer Treatment and Research
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.